Randomized trial to assess efficacy and safety of an add-on treatment with zonisamide in adults with focal epileptic seizures with or without secondary generalization.

Trial Profile

Randomized trial to assess efficacy and safety of an add-on treatment with zonisamide in adults with focal epileptic seizures with or without secondary generalization.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 29 Aug 2014

At a glance

  • Drugs Zonisamide (Primary)
  • Indications Partial epilepsies
  • Focus Therapeutic Use
  • Sponsors Eisai Co Ltd
  • Most Recent Events

    • 18 Aug 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 18 Jul 2008 Planned patient numbers identified as 200 by ClinicalTrials.gov.
    • 18 Jul 2008 The expected completion date for this trial has been identified as Jul 2008, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top